Suppr超能文献

微小RNA-374a通过靶向轴抑制蛋白2促进骨肉瘤细胞增殖。

MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2.

作者信息

Lu Tan, Zhang Chao, Chai Ming-Xiang, An Yong-Bo, Jia Jin-Ling

机构信息

Department of Orthopedics, The First Affiliated Hospital of Xinxiang Medical University Weihui 453100, China.

出版信息

Int J Clin Exp Pathol. 2015 Sep 1;8(9):10776-83. eCollection 2015.

Abstract

BACKGROUND

MicroRNA-374a (miR-374a) has been implicated in several cancers. However, its role in osteosarcoma (OS) remains unclear. Thus the aim of this study was to investigate its expression and role in progression of OS.

METHODS

Quantitative real-time PCR (qRT-PCR) was performed to detect the expression of miR-374a in OS cell lines and tissues. To further understand its role, we restored expression of miR-374a in MG63 cell line by transfection with miR-374a mimics or inhibitors. Effects of miR-374a on cell proliferation on targets were also determined.

RESULTS

In the present study, our results showed that miR-374a was significantly up-regulated in both OS cell lines and OS tissues. Over expression of miR-374a markedly accelerated proliferation of OS cells, while its inhibition significantly suppressed cell proliferation. Moreover, Axin2 was identified to be a functional downstream target of miR-374a, and decreased expression of Axin2 could promote OS cell proliferation.

CONCLUSION

Our study suggested that miR-374a functions as an oncogene in OS, and the miR-374a/Axin2 axis might represent a potential therapeutic target for OS intervention.

摘要

背景

微小RNA-374a(miR-374a)已被证实与多种癌症有关。然而,其在骨肉瘤(OS)中的作用仍不清楚。因此,本研究旨在探讨其在骨肉瘤进展中的表达及作用。

方法

采用定量实时聚合酶链反应(qRT-PCR)检测miR-374a在骨肉瘤细胞系和组织中的表达。为进一步了解其作用,我们通过转染miR-374a模拟物或抑制剂来恢复MG63细胞系中miR-374a的表达。还确定了miR-374a对细胞增殖靶点的影响。

结果

在本研究中,我们的结果表明miR-374a在骨肉瘤细胞系和骨肉瘤组织中均显著上调。miR-374a的过表达显著加速了骨肉瘤细胞的增殖,而其抑制则显著抑制了细胞增殖。此外,Axin2被确定为miR-374a的功能性下游靶点,Axin2表达的降低可促进骨肉瘤细胞增殖。

结论

我们的研究表明,miR-374a在骨肉瘤中起癌基因作用,miR-374a/Axin2轴可能是骨肉瘤干预的潜在治疗靶点。

相似文献

1
MiR-374a promotes the proliferation of osteosarcoma cell proliferation by targeting Axin2.
Int J Clin Exp Pathol. 2015 Sep 1;8(9):10776-83. eCollection 2015.
2
Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4.
Biomed Pharmacother. 2015 Oct;75:1-7. doi: 10.1016/j.biopha.2015.08.012. Epub 2015 Aug 27.
3
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
Clin Exp Med. 2017 Feb;17(1):51-58. doi: 10.1007/s10238-015-0398-6. Epub 2015 Oct 29.
4
MicroRNA-374a promotes esophageal cancer cell proliferation via Axin2 suppression.
Oncol Rep. 2015 Oct;34(4):1988-94. doi: 10.3892/or.2015.4182. Epub 2015 Aug 7.
8
MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1.
Pathol Oncol Res. 2020 Jan;26(1):533-539. doi: 10.1007/s12253-018-0556-8. Epub 2018 Dec 6.
10
miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22.
Med Sci Monit. 2017 Feb 24;23:1001-1008. doi: 10.12659/msm.900084.

引用本文的文献

1
GATA2‑miR‑374a axis promotes vascular smooth muscle cells proliferation, migration via targeting circTADA2A/RORA axis.
Exp Ther Med. 2024 Jul 8;28(3):357. doi: 10.3892/etm.2024.12646. eCollection 2024 Sep.
2
Osteoclast microRNA Profiling in Rheumatoid Arthritis to Capture the Erosive Factor.
JBMR Plus. 2023 Jun 5;7(8):e10776. doi: 10.1002/jbm4.10776. eCollection 2023 Aug.
4
MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma.
J Pathol Transl Med. 2019 Nov;53(6):354-360. doi: 10.4132/jptm.2019.10.01. Epub 2019 Oct 24.
6
miRNA signatures in childhood sarcomas and their clinical implications.
Clin Transl Oncol. 2019 Dec;21(12):1583-1623. doi: 10.1007/s12094-019-02104-z. Epub 2019 Apr 4.
7
MicroRNA-374a Governs Aggressive Cell Behaviors of Glioma by Targeting Prokineticin 2.
Technol Cancer Res Treat. 2019 Jan 1;18:1533033818821401. doi: 10.1177/1533033818821401.
8
Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.
Invest New Drugs. 2018 Dec;36(6):1116-1132. doi: 10.1007/s10637-018-0624-7. Epub 2018 Aug 6.
9
Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.
Medicine (Baltimore). 2018 Jun;97(25):e10996. doi: 10.1097/MD.0000000000010996.
10
PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition.
Oncotarget. 2017 Mar 22;8(35):58184-58198. doi: 10.18632/oncotarget.16436. eCollection 2017 Aug 29.

本文引用的文献

1
miR-374a promotes cell proliferation, migration and invasion by targeting SRCIN1 in gastric cancer.
FEBS Lett. 2015 Jan 30;589(3):407-13. doi: 10.1016/j.febslet.2014.12.027. Epub 2014 Dec 29.
2
4
Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer.
Cell Death Dis. 2014 May 15;5(5):e1227. doi: 10.1038/cddis.2014.186.
5
Increased microRNA-630 expression in gastric cancer is associated with poor overall survival.
PLoS One. 2014 Mar 12;9(3):e90526. doi: 10.1371/journal.pone.0090526. eCollection 2014.
7
[Expression of circulating microRNAs in patients with bladder urothelial carcinoma].
Beijing Da Xue Xue Bao Yi Xue Ban. 2013 Aug 18;45(4):532-6.
8
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.
J Clin Invest. 2013 Feb;123(2):566-79. doi: 10.1172/JCI65871. Epub 2013 Jan 16.
9
miRNA signatures associate with pathogenesis and progression of osteosarcoma.
Cancer Res. 2012 Apr 1;72(7):1865-77. doi: 10.1158/0008-5472.CAN-11-2663. Epub 2012 Feb 20.
10
Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Genes Chromosomes Cancer. 2011 Oct;50(10):812-22. doi: 10.1002/gcc.20902. Epub 2011 Jul 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验